Existing data sources for clinical epidemiology: The north denmark bacteremia research database

Clinical Epidemiology

Volumn 2, Issue 1, 2010, Pages 171-178

  Schønheyder, Henrik C ^a   Søgaard, Mette ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bloodstream infection; Epidemiology; Population based; Register

Indexed keywords

ANTIBIOTIC AGENT;

ACCESS TO INFORMATION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM ISOLATION; BIOINFORMATICS; BLOOD CULTURE; BLOODSTREAM INFECTION; COHORT ANALYSIS; COMORBIDITY; DENMARK; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; MICROBIAL IDENTIFICATION; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; POPULATION RESEARCH; PROGNOSIS; REGISTER; SURVIVAL TIME; TREATMENT RESPONSE; ANTIBIOTIC THERAPY; BROTH DILUTION; COMMUNICABLE DISEASE; COMPUTER PROGRAM; CRITERION VARIABLE; DIAGNOSTIC KIT; DISEASE REGISTRY; FACTUAL DATABASE; FUNGEMIA; GRAM NEGATIVE BACTERIUM; HEALTH SURVEY; HOSPITAL DEPARTMENT; HOSPITAL INFECTION; INFECTION; INFORMATION PROCESSING; INFORMATION SYSTEM; MEDICAL HISTORY; MICROORGANISM; PRACTICE GUIDELINE; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL PREDICTION;

EID: 77955368966     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/clep.s10139     Document Type: Article

References (71)

1. Bennett I, Beeson P. Bacteremia: a consideration of some clinical and experimental aspects. Yale J Biol Med. 1954;26(4):241-462.
2. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fungemia. JAMA. 1995;274(10):807-812.
3. Bates DW, Pruess KE, Lee TH. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med. 1995;155(6):593-598.
4. Bulloch W. The History of Bacteriology. New York: Dover Publication, Inc.; 1979 (first published 1938 by Oxford University Press).
5. McGowan JE Jr, Barnes MW, Finland M. Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935- 1972), with special reference to hospital-acquired cases. J Infect Dis. 1975;132(3):316-335.
6. Freedman RM, Ingram DL, Gross I, Ehrenkranz RA, Warshaw JB, Baltimore RS. A half century of neonatal sepsis at Yale: 1928 to 1978. Am J Dis Child. 1981;135(2):140-144.
7. Austriam R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60(5):759-776.
8. Faber V, Jessen O, Rosendal K, Eriksen KR. Staphylococcal bacteraemia. Clinical and bacteriological observations in 201 cases. Br Med J. 1960;2(5216):1832-1836.
9. Jessen O, Rosendal K, Bülow P, Faber V, Eriksen KR. Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia. N Engl J Med. 1969;281(12):627-635.
10. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med. 1962;110:845-855.
11. DuPont HL, Spink WW. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969;48(4):307-332.
12. McCabe WR, Jackson GG. Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations. Arch Intern Med. 1962;110:856-864.
13. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980;68(3):332-343.
14. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med. 1980;68(3):344-355.
15. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis. 1983;5(1):35-53.
16. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis. 1983;5(1):54-70.
17. Flournoy DJ, Belknap DC. The relationship of septicemia-related diagnoses and positive blood cultures. Mil Med. 1991;156(9):452-454.
18. Jhung MA, Banerjee SN. Administrative coding data and health careassociated infections. Clin Infect Dis. 2009;49(6):949-955.
19. Madsen M, Schønheyder HC, Kristensen B, Nielsen GL, Sørenser HT. Can hospital discharge diagnosis be used for surveillance of bacteremia? A data quality study of a Danish hospital discharge registry. Infect Control Hosp Epidemiol. 1998;19(3):175-180.
20. Gransden WR, Eykyn SJ, Phillips I. Staphylococcus aureus bacteraemia: 400 episodes in St Thomas's Hospital. Br Med J 1984;288(6413):300-303.
21. Gransden WR, Eykyn SJ, Phillips I. The computerized documentation of septicaemia. J Antimicrob Chemother. 1990 April;25 Suppl C:31-39.
22. Leibovici L, Konisberger H, Pitlik SD, Samra Z, Drucker M. Bacteremia and fungemia of unknown origin in adults. Clin Infect Dis. 1992;14(2):436-443.
23. Leibovici L, Konisberger H, Pitlik SD, Samra Z, Drucker M. Patients at risk for inappropriate antibiotic treatment of bacteraemia. J Intern Med. 1992;231(4):371-374.
24. Kristensen B, Smedegaard HH, Pedersen HM, et al. Antibiotic resistance patterns among blood culture isolates in a Danish county 1981-1995. J Med Microbiol. 1999;48(1):67-71.
25. Schønheyder HC, Højbjerg T. The impact of the first notification of positive blood cultures on antibiotic therapy. A one-year survey. APMIS.1995;103(1):37-44.
26. Schønheyder HC. Two thousands seven hundred and thirty nine episodes of bacteremia in the county of Northern Jutland 1996- 1998. Presentation of a regional clinical database. Ugeskr Læger. 2000;162(20):2886-2891.
27. Washington JA. Blood cultures: principles and techniques. Mayo Clin Proc. 1975;50(2):91-98.
28. Bryan CS. Clinical implications of positive blood cultures. Clin Microbiol Rev. 1989;2(4):329-353.
29. Gradel KO, Søgaard M, Dethlefsen C, Nielsen H, Schønheyder HC. Magnitude of bacteraemia is a predictor of mortality during 1 year of follow-up. Epidemiol Infect. 2009;137(1):94-101.
30. Madsen KM, Schønheyder HC, Kristensen B, Sørensen HT. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981-1994. APMIS. 1999;107(3):346-352.
31. Pedersen G, Schønheyder HC, Sørensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia - a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect. 2003;9(8):793-802.
32. Pedersen G, Schønheyder HC, Kristensen B, Sørensen HT. Communityacquired bacteraemia and antibiotic resistance. Trends during a 17-year period in a Danish county. Dan Med Bull. 2000;47(4):296-300.
33. Jensen US, Knudsen JD, Østergaard C, Gradel KO, Frimodt-Møller N, Schønheyder HC. Recurrent bacteraemia: A 10-year regional population- based study of clinical and microbiological risk factors. J Infect. 2009; [Epub ahead of print].
34. Bruun B, Sloth K, Bentzon MW, Frederiksen W. A study of bacteremias in Denmark from 1977-1978. Acta Pathol Microbiol Immunol Scand B. 1982;90(4):309-317.
35. Roberts FJ. A review of positive blood cultures: identification and source of microorganisms and patterns of sensitivity to antibiotics. Rev Infect Dis. 1980;2(3):329-339.
36. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis. 1991;13(1):34-46.
37. Roberts FJ. Definition of polymicrobial bacteremia. Rev Infect Dis. 1989;11(6):1029-1030.
38. Hindsholm M, Schønheyder HC. Clinical presentation and outcome of bacteraemia caused by beta-haemolytic streptococci serogroup G. APMIS. 2002;110(7-8):554-558.
39. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-140.
40. Graham DR, Keldermans MM, Klemm LW, Semenza NJ, Shafer ML. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med. 1991;91(3B):95S-100S.
41. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis. 2002;34(11):1431-1439.
42. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community- acquired infections. Ann Intern Med. 2002;137(10):791-797.
43. Tambyah PA, Habib AG, Ng TM, Goh H, Kumarasinghe G. Community- acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated". Infect Control Hosp Epidemiol. 2003;24(6):436-438.
44. Valles J, Calbo E, Anoro E, et al. Bloodstream infections in adults: importance of healthcare-associated infections. J Infect. 2008; 56(1):27-34.
45. Justensen T, Korsager B, Kolmos HJ, Gerstoff J. Vejledning i brug af antibiotika. In: Hansen M, Ampmann JP, Vej-Hansen B, editors. Lægeforeningens Medicinfortegnelse. København: Lægemiddelforeningens Forlag; 2005. p. 853-876.
46. Medicin.dk [homepage on the Internet]. Available from: www.medicin. dk. Accessed 2010 January 4.
47. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population- based study among adults. Clin Infect Dis. 2005;40(4):628-631.
48. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol. 1992;135(9):1042-1050.
49. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO. Bacteremia at a Danish university hospital during a twenty-five-year period (1968-1992). Scand J Infect Dis. 1995;27(3):245-251.
50. Geerdes HF, Ziegler D, Lode H, et al. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis. 1992;15(6):991-1002.
51. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis. 1994;19(2):246-256.
52. Pedersen G, Schønheyder HC, Sørensen HT. Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study. Scand J Infect Dis. 1997;29(6):601-606.
53. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992;101(6):1481-1483.
54. Hanon FX, Monnet DL, Sørensen TL, Mølbak K, Pedersen G, Schønheyder HC. Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis. 2002;34(7):520-528.
55. Thomsen RW, Hundborg HH, Johnsen SP, et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med. 2006;34(4):1080-1086.
56. Thulstrup AM, Sørensen HT, Schønheyder HC, Møller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis. 2000;31(6):1357-1361.
57. Linderoth G, Jepsen P, Schønheyder HC, Johnsen SP, Sørensen HT. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study. Alcohol Clin Exp Res. 2006;30(4):636-641.
58. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Sørensen HT, Schønheyder HC. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care. 2004;27(1):70-76.
59. Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT. Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect. 2006;12(3):217-223.
60. Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT. Haematological malignancies-a predictor of a poor outcome in patients with bacteraemia. J Infect. 2006;53(3):190-198.
61. Søgaard M, Schønheyder HC, Riis A, Sørensen HT, Nørgaard M. Short-term mortality in relation to age and comorbidity in older adults with community-acquired bacteremia: a population-based cohort study. J Am Geriatr Soc. 2008;56(9):1593-1600.
62. Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Rothman KJ, Sørensen HT. Short-term mortality of bacteraemia in elderly patients with haematological malignancies. Br J Haematol. 2006;132(1):25-31.
63. Freundlich M, Thomsen RW, Pedersen L, West H, Schønheyder HC. Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study. J Antimicrob Chemother. 2007;60(5):1115-1123.
64. Pedersen G, Schønheyder HC, Steffensen FH, Sørensen HT. Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia. J Antimicrob Chemother. 1999;43(1):119-126.
65. Kristensen B, Andreassen S, Leibovici L, Riekehr C, Kjaer AG, Schønheyder HC. Empirical treatment of bacteraemic urinary tract infection. Evaluation of a decision support system. Dan Med Bull. 1999;46(4):349-353.
66. Andreassen S, Riekehr C, Kristensen B, Schønheyder HC, Leibovici L. Using probabilistic and decision-theoretic methods in treatment and prognosis modeling. Artif Intell Med. 1999;15(2):121-134.
67. Bukh AS, Schønheyder HC, Emmersen JM, Søgaard M, Bastholm S, Roslev P. Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J Antimicrob Chemother. 2009;64(1):163-168.
68. Jensen US, Østergaard C, Schønheyder HC, Knudsen JD. Creating a collaborative network for the study of bacteremia in Denmark: frequency of recurrence with the same and different micro-organisms. European Congress of Clinical Microbiology and Infectious Diseases, Helsinki; 2009 May 16-19 [Poster 1437].
69. Laupland KB, Schønheyder HC, Kennedy KJ, et al. Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative. BMC Res Notes. 2009;2:146.
70. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57(6):441-448.